Pub-2001-2002

Articles

Title
Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications
Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications
Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications
Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications
CD20-Directed Antibody-Mediated Immunotherapy Induces Responses and Facilitates Hematologic Recovery in Patients With Waldenstrom's Macroglobulinemia
CD20-directed serotherapy in patients with multiple myeloma: biologic considerations and therapeutic applications
Concepts in the use of TRAIL/Apo2L: an emerging biotherapy for myeloma and other neoplasias
Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cells
Molecular sequelae of proteasome inhibition in human multiple myeloma cells
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma
TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications
Tumor Cell Expression of CD59 Is Associated With Resistance to CD20 Serotherapy in Patients With B-Cell Malignancies